Oral medicine for anemia after hip or knee replacement
Part of Blood & lymphatic clinical trials.
This trial tests an oral medication called SSS17 to treat anemia after hip or knee replacement surgery. It is for people with mild to moderate anemia who are scheduled for surgery and have no other major health problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old and planning to have hip or knee replacement surgery.
- Your blood test shows lower-than-normal red blood cell count (hemoglobin between 8 and 11 g/dL), but not low enough to need a transfusion.
- You do not have a blood clot in your leg (confirmed by ultrasound before surgery).
- You do not have other causes of anemia, such as chronic disease or bleeding problems.
- You agree to use effective birth control (if applicable) and follow study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, HS-20106, to see if it can improve low red blood cell counts (anemia) for people with a certain type of bone marrow disorder called myelodysplastic syndromes (MDS), which is not high risk. It might be an option if you have not received certain prior treatments.
This trial tests a powder called SURGICEL® that may help control bleeding during knee replacement surgery. People with severe knee arthritis who are having their first knee replacement may be able to join.
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
This trial tests whether an oral nutrition plan given before elective hip or knee replacement can help people with low nutrition (“malnutrition”) do better after surgery. If you’re a candidate for surgery and meet lab signs of poor nutrition, you may be asked to take an oral supplement by mouth.
This trial tests a combined treatment plan to improve anemia (low blood count/iron levels) before and around the time of major elective heart surgery. It may help reduce the need for blood transfusions and support safer recovery.
This study tests a new injection called SRSD107 to see if it prevents blood clots after knee replacement surgery, compared to a standard blood thinner (enoxaparin). It might be an option if you are having a planned knee replacement and are otherwise healthy.
Hear when a new Arthroplasty, Replacement, Hip trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.